Dexmethylphenidate HCl is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Adare Pharmaceuticals Inc. The primary component is Dexmethylphenidate Hydrochloride.
| Product ID | 59917-110_ad9630c5-54f3-4595-b6fd-9a0112a6628b |
| NDC | 59917-110 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dexmethylphenidate HCl |
| Generic Name | Dexmethylphenidate Hcl Extended-release |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-11-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA210279 |
| Labeler Name | Adare Pharmaceuticals Inc |
| Substance Name | DEXMETHYLPHENIDATE HYDROCHLORIDE |
| Active Ingredient Strength | 25 mg/1 |
| Pharm Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2018-11-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Ingredient | Strength |
|---|---|
| DEXMETHYLPHENIDATE HYDROCHLORIDE | 25 mg/1 |
| SPL SET ID: | c35cb07b-f176-4155-b5be-93e341aa4856 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 59917-106 | Dexmethylphenidate HCl | Dexmethylphenidate HCl Extended-Release |
| 59917-107 | Dexmethylphenidate HCl | Dexmethylphenidate HCl Extended-Release |
| 59917-108 | Dexmethylphenidate HCl | Dexmethylphenidate HCl Extended-Release |
| 59917-109 | Dexmethylphenidate HCl | Dexmethylphenidate HCl Extended-Release Capsules, 20 mg |
| 59917-110 | Dexmethylphenidate HCl | Dexmethylphenidate HCl Extended-Release |
| 59917-111 | Dexmethylphenidate HCl | Dexmethylphenidate HCl Extended-Release |
| 59917-112 | Dexmethylphenidate HCl | Dexmethylphenidate HCl Extended-Release |
| 59917-113 | Dexmethylphenidate HCl | Dexmethylphenidate HCl Extended-Release |